Abnormalities of Preoperative Ascending Urethrocystography and Outcomes of Living Donor Kidney Transplantation

Launched by ASSIUT UNIVERSITY · Dec 11, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how certain issues found during a specific type of imaging test called ascending urethrocystography (AUC) might affect the short-term success of living donor kidney transplants (LDKT). The goal is to see if these abnormalities have any impact on how well patients do after receiving a kidney from a living donor.

To be eligible for this study, participants need to be between the ages of 18 and 29 and must be undergoing a kidney transplant at the Assiut Kidney Transplantation Unit. They should also have had the AUC test as part of their preoperative evaluation. Patients who have experienced a non-functioning kidney transplant, those who lack important pre- or post-surgery information, or those who choose not to participate will not be included in the trial. If you decide to take part, you'll be helping researchers understand more about how these imaging findings relate to transplant outcomes, which could improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pediatric and adult patients undergoing LDKT in Assiut Kidney Transplantation Unit.
• • Patients with preoperative evaluation by AUC.
• Exclusion Criteria:
• • Patients with a primary non-functioning graft after LDKT.
• • Patients with missing relevant preoperative or postoperative data.
• • Patients refusal to participate in the study.